About the Van Andel Institute:
Jay and Betty Van Andel founded Van Andel Institute (VAI) in 1996. Together, they envisioned an institute that would have an impact world-wide in enriching and enhancing lives through biomedical research and education. Since its grand opening in 2000, VAI has supported Van Andel Research Institute (VARI) and Van Andel Education Institute (VAEI) in fulfilling and sustaining this vision.
VARI has reflected this vision through remarkable strides in basic and translational research. This research has led to advances in cancer diagnosis, treatment, and prevention, and the establishment of an excellent reputation among peer institutions. Through its work with students of all ages, VAEI has built a regional and national reputation as a source of well-reasoned, carefully documented and trustworthy insights regarding the ways in which we teach and learn science.
David Van Andel leads the Institute as Chairman and CEO, continuing the legacy that his parents left behind
GRAND RAPIDS, MI - Discoveries by scientists at Van Andel Research Institute have led to new diagnostic tests for cancer that will be manufactured by a Danish company, institute officials announced Wednesday.
"It's a great milestone," said George Vande Woude, the institute's founding research director.
The VARI's licensing agreement with Dako, a Denmark-based provider of diagnostic products, holds hope for improving treatments for as many as 30 forms of cancer, including breast, prostate and liver cancer, as well as lymphomas. They target subtypes that involve the expression of the MET gene discovered by Vande Woude in 1984.